Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Convallatoxin-Induced Reduction of Methionine Import Effectively Inhibits Human Cytomegalovirus Infection and Replication.

Cohen T, Williams JD, Opperman TJ, Sanchez R, Lurain NS, Tortorella D.

J Virol. 2016 Nov 14;90(23):10715-10727. Print 2016 Dec 1.

2.

The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women.

Lurain NS, Hanson BA, Hotton AL, Weber KM, Cohen MH, Landay AL.

AIDS Res Hum Retroviruses. 2016 Feb;32(2):134-43. doi: 10.1089/AID.2015.0169. Epub 2015 Oct 22.

3.

Subtherapeutic ganciclovir (GCV) levels and GCV-resistant cytomegalovirus in lung transplant recipients.

Gagermeier JP, Rusinak JD, Lurain NS, Alex CG, Dilling DF, Wigfield CH, Love RB.

Transpl Infect Dis. 2014 Dec;16(6):941-50. doi: 10.1111/tid.12317. Epub 2014 Dec 10.

PMID:
25491023
4.

Reply to Itzhaki and Klapper.

Lurain NS, Hanson BA, Martinson J, Leurgans SE, Landay AL, Bennett DA, Schneider JA.

J Infect Dis. 2014 Mar;209(6):974. doi: 10.1093/infdis/jit666. Epub 2013 Nov 26. No abstract available.

5.

CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells.

Šedý JR, Bjordahl RL, Bekiaris V, Macauley MG, Ware BC, Norris PS, Lurain NS, Benedict CA, Ware CF.

J Immunol. 2013 Jul 15;191(2):828-36. doi: 10.4049/jimmunol.1300894. Epub 2013 Jun 12.

6.

Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease.

Lurain NS, Hanson BA, Martinson J, Leurgans SE, Landay AL, Bennett DA, Schneider JA.

J Infect Dis. 2013 Aug 15;208(4):564-72. doi: 10.1093/infdis/jit210. Epub 2013 May 9.

7.

Modeling of human cytomegalovirus maternal-fetal transmission in a novel decidual organ culture.

Weisblum Y, Panet A, Zakay-Rones Z, Haimov-Kochman R, Goldman-Wohl D, Ariel I, Falk H, Natanson-Yaron S, Goldberg MD, Gilad R, Lurain NS, Greenfield C, Yagel S, Wolf DG.

J Virol. 2011 Dec;85(24):13204-13. doi: 10.1128/JVI.05749-11. Epub 2011 Oct 5.

8.

Cytomegalovirus viraemia in the modern antiretroviral era(*).

Jacobson M, Lurain N, Hunt P.

HIV Med. 2011 Aug;12(7):387-8. doi: 10.1111/j.1468-1293.2010.00899.x. No abstract available.

9.

Multilaboratory evaluation of real-time PCR tests for hepatitis B virus DNA quantification.

Caliendo AM, Valsamakis A, Bremer JW, Ferreira-Gonzalez A, Granger S, Sabatini L, Tsongalis GJ, Wang YF, Yen-Lieberman B, Young S, Lurain NS.

J Clin Microbiol. 2011 Aug;49(8):2854-8. doi: 10.1128/JCM.00471-11. Epub 2011 Jun 22.

10.

Antiviral drug resistance of human cytomegalovirus.

Lurain NS, Chou S.

Clin Microbiol Rev. 2010 Oct;23(4):689-712. doi: 10.1128/CMR.00009-10. Review.

11.

Multisite comparison of anti-human immunodeficiency virus microbicide activity in explant assays using a novel endpoint analysis.

Richardson-Harman N, Lackman-Smith C, Fletcher PS, Anton PA, Bremer JW, Dezzutti CS, Elliott J, Grivel JC, Guenthner P, Gupta P, Jones M, Lurain NS, Margolis LB, Mohan S, Ratner D, Reichelderfer P, Roberts P, Shattock RJ, Cummins JE Jr.

J Clin Microbiol. 2009 Nov;47(11):3530-9. doi: 10.1128/JCM.00673-09. Epub 2009 Sep 2.

12.

High-throughput sequence analysis of variants of human cytomegalovirus strains Towne and AD169.

Bradley AJ, Lurain NS, Ghazal P, Trivedi U, Cunningham C, Baluchova K, Gatherer D, Wilkinson GW, Dargan DJ, Davison AJ.

J Gen Virol. 2009 Oct;90(Pt 10):2375-80. doi: 10.1099/vir.0.013250-0. Epub 2009 Jun 24.

13.

Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation.

Shapira MY, Resnick IB, Chou S, Neumann AU, Lurain NS, Stamminger T, Caplan O, Saleh N, Efferth T, Marschall M, Wolf DG.

Clin Infect Dis. 2008 May 1;46(9):1455-7. doi: 10.1086/587106.

PMID:
18419454
14.

Upregulation of human cytomegalovirus by HIV type 1 in human lymphoid tissue ex vivo.

Biancotto A, Iglehart SJ, Lisco A, Vanpouille C, Grivel JC, Lurain NS, Reichelderfer PS, Margolis LB.

AIDS Res Hum Retroviruses. 2008 Mar;24(3):453-62. doi: 10.1089/aid.2007.0155.

PMID:
18327985
16.

Human cytomegalovirus and human immunodeficiency virus type-1 co-infection in human cervical tissue.

Fox-Canale AM, Hope TJ, Martinson J, Lurain JR, Rademaker AW, Bremer JW, Landay A, Spear GT, Lurain NS.

Virology. 2007 Dec 5;369(1):55-68. Epub 2007 Aug 22.

17.

Evaluation of real-time PCR laboratory-developed tests using analyte-specific reagents for cytomegalovirus quantification.

Caliendo AM, Ingersoll J, Fox-Canale AM, Pargman S, Bythwood T, Hayden MK, Bremer JW, Lurain NS.

J Clin Microbiol. 2007 Jun;45(6):1723-7. Epub 2007 Apr 4.

18.

Multilaboratory comparison of hepatitis C virus viral load assays.

Caliendo AM, Valsamakis A, Zhou Y, Yen-Lieberman B, Andersen J, Young S, Ferreira-Gonzalez A, Tsongalis GJ, Pyles R, Bremer JW, Lurain NS.

J Clin Microbiol. 2006 May;44(5):1726-32.

19.
20.

Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway.

Cheung TC, Humphreys IR, Potter KG, Norris PS, Shumway HM, Tran BR, Patterson G, Jean-Jacques R, Yoon M, Spear PG, Murphy KM, Lurain NS, Benedict CA, Ware CF.

Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13218-23. Epub 2005 Aug 30.

21.

Emergence and compartmentalization of fatal multi-drug-resistant cytomegalovirus infection in a patient with autosomal-recessive severe combined immune deficiency.

Blackman SC, Lurain NS, Witte DP, Filipovich AH, Groen P, Schleiss MR.

J Pediatr Hematol Oncol. 2004 Sep;26(9):601-5.

PMID:
15342989
22.

HIV type 1 and cytomegalovirus coinfection in the female genital tract.

Lurain NS, Robert ES, Xu J, Camarca M, Landay A, Kovacs AA, Reichelderfer PS.

J Infect Dis. 2004 Aug 1;190(3):619-23. Epub 2004 Jun 30.

23.

Comparison of molecular tests for detection and quantification of cell-associated cytomegalovirus DNA.

Caliendo AM, Yen-Lieberman B, Baptista J, Andersen J, Crumpacker C, Schuurman R, Spector SA, Bremer J, Lurain NS.

J Clin Microbiol. 2003 Aug;41(8):3509-13.

24.

Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus.

Chou S, Lurain NS, Thompson KD, Miner RC, Drew WL.

J Infect Dis. 2003 Jul 1;188(1):32-9. Epub 2003 Jun 16. Erratum in: J Infect Dis. 2004 Sep 15;190(6):1202.

PMID:
12825168
25.

Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.

Weinberg A, Jabs DA, Chou S, Martin BK, Lurain NS, Forman MS, Crumpacker C; Cytomegalovirus Retinitis and Viral Resistance Study Group; Adult AIDS Clinical Trials Group Cytomegalovirus Laboratories.

J Infect Dis. 2003 Mar 1;187(5):777-84. Epub 2003 Feb 24.

PMID:
12599051
26.

Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infection.

Isada CM, Yen-Lieberman B, Lurain NS, Schilz R, Kohn D, Longworth DL, Taege AJ, Mossad SB, Maurer J, Flechner SM, Mawhorter SD, Braun W, Gordon SM, Schmitt SK, Goldman M, Long J, Haug M, Avery RK.

Transpl Infect Dis. 2002 Dec;4(4):189-94.

PMID:
12535261
27.

Emergence of ganciclovir-resistant cytomegalovirus in lung transplant recipients.

Bhorade SM, Lurain NS, Jordan A, Leischner J, Villanueva J, Durazo R, Creech S, Vigneswaran WT, Garrity ER.

J Heart Lung Transplant. 2002 Dec;21(12):1274-82.

PMID:
12490272
28.

Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients.

Wolf DG, Lurain NS, Zuckerman T, Hoffman R, Satinger J, Honigman A, Saleh N, Robert ES, Rowe JM, Kra-Oz Z.

Blood. 2003 Jan 15;101(2):463-5. Epub 2002 Aug 22.

29.

Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients.

Lurain NS, Bhorade SM, Pursell KJ, Avery RK, Yeldandi VV, Isada CM, Robert ES, Kohn DJ, Arens MQ, Garrity ER, Taege AJ, Mullen MG, Todd KM, Bremer JW, Yen-Lieberman B.

J Infect Dis. 2002 Sep 15;186(6):760-8. Epub 2002 Aug 28.

PMID:
12198609
30.

Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing.

Lurain NS, Weinberg A, Crumpacker CS, Chou S; Adult AIDS Clinical Trials Group-CMV Laboratories.

Antimicrob Agents Chemother. 2001 Oct;45(10):2775-80.

31.

Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma.

Caliendo AM, Schuurman R, Yen-Lieberman B, Spector SA, Andersen J, Manjiry R, Crumpacker C, Lurain NS, Erice A; CMV Working Group of the Complications of HIV Disease RAC, AIDS Clinical Trials Group.

J Clin Microbiol. 2001 Apr;39(4):1334-8.

32.

Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide.

Waldman WJ, Knight DA, Blinder L, Shen J, Lurain NS, Miller DM, Sedmak DD, Williams JW, Chong AS.

Intervirology. 1999;42(5-6):412-8.

PMID:
10702725
33.

Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates.

Lurain NS, Kapell KS, Huang DD, Short JA, Paintsil J, Winkfield E, Benedict CA, Ware CF, Bremer JW.

J Virol. 1999 Dec;73(12):10040-50.

34.

Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide.

Waldman WJ, Knight DA, Lurain NS, Miller DM, Sedmak DD, Williams JW, Chong AS.

Transplantation. 1999 Sep 27;68(6):814-25.

PMID:
10515382
35.

Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus.

Benedict CA, Butrovich KD, Lurain NS, Corbeil J, Rooney I, Schneider P, Tschopp J, Ware CF.

J Immunol. 1999 Jun 15;162(12):6967-70.

36.
37.

Rapid ganciclovir susceptibility assay using flow cytometry for human cytomegalovirus clinical isolates.

McSharry JJ, Lurain NS, Drusano GL, Landay AL, Notka M, O'Gorman MR, Weinberg A, Shapiro HM, Reichelderfer PS, Crumpacker CS.

Antimicrob Agents Chemother. 1998 Sep;42(9):2326-31.

38.

Flow cytometric determination of ganciclovir susceptibilities of human cytomegalovirus clinical isolates.

McSharry JM, Lurain NS, Drusano GL, Landay A, Manischewitz J, Nokta M, O'Gorman M, Shapiro HM, Weinberg A, Reichelderfer P, Crumpacker C.

J Clin Microbiol. 1998 Apr;36(4):958-64.

39.

Molecular analysis of human cytomegalovirus strains from two lung transplant recipients with the same donor.

Lurain NS, Ammons HC, Kapell KS, Yeldandi VV, Garrity ER, O'Keefe JP.

Transplantation. 1996 Aug 27;62(4):497-502.

PMID:
8781616
41.
42.
43.
44.

In situ ELISA for the evaluation of antiviral compounds effective against human cytomegalovirus.

Tatarowicz WA, Lurain NS, Thompson KD.

J Virol Methods. 1991 Nov-Dec;35(2):207-15.

PMID:
1667788

Supplemental Content

Loading ...
Support Center